Ultra‐High‐Performance Liquid Chromatography‐Tandem Mass Spectrometry Combined With Network Pharmacology to Elucidate the Bioactive Ingredients and Potential Mechanism of Wu‐Teng Decoction for Treatment of Rheumatoid Arthritis
Chemistry & Biodiversity · 2025
DOI: 10.1002/cbdv.202403454 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Wei Zou und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Guilin Medical University, Guilin, China. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Network Pharmacology, Drugs, Chinese Herbal. Die Arbeit nennt 47 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangxi Zhuang Autonomous Region.
Abstract (Originalsprache)
Wu‐Teng Decoction (WTD) is a significant in‐hospital preparation widely used in clinical practice to treat rheumatoid arthritis (RA) in China, however, its active substances and underlying mechanisms remain unclear. In this study, the chemical constituents of WTD were analyzed using ultra‐high‐performance liquid chromatography‐tandem mass spectrometry, identifying a total of 120 compounds, including flavonoids, phenylpropanoids, phenolic acids, alkaloids, etc. Subsequently, network pharmacology analyses revealed that 29 compounds were potential active compounds in WTD for the treatment of RA, as well as 48 core anti‐RA targets, including tumor necrosis factor‐α, V‐Akt murine thymoma viral oncogene homolog 1, and albumin. Further analysis suggested that WTD treats RA via the phosphoinositide 3‐kinase‐Akt, mitogen‐activated protein kinase, and Ras signaling pathways. Molecular docking analysis of the top five pivotal targets with the core active ingredients demonstrated suitable binding interactions at the active site of target proteins. The significant reduction of nitric oxide levels in lipopolysaccharides‐induced RAW264.7 cells validated the anti‐inflammation activity of WTD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Guilin Medical University, Guilin, China.
- Department of Traditional Chinese Medicine, Affiliated Hospital of Guilin Medical University, Guilin, China.
- Guangxi Key Laboratory of Drug Discovery and Optimization, Guilin Medical University, Guilin, China.
ORCID-Profile: Qingang Tan
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Guangxi Zhuang Autonomous Region
Zitieren
APA
Zou, W., Wang, B., Feng, X., Lai, C., & Tan, Q. (2025). Ultra‐High‐Performance Liquid Chromatography‐Tandem Mass Spectrometry Combined With Network Pharmacology to Elucidate the Bioactive Ingredients and Potential Mechanism of Wu‐Teng Decoction for Treatment of Rheumatoid Arthritis. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202403454
Vancouver
Zou W, Wang B, Feng X, Lai C, Tan Q. Ultra‐High‐Performance Liquid Chromatography‐Tandem Mass Spectrometry Combined With Network Pharmacology to Elucidate the Bioactive Ingredients and Potential Mechanism of Wu‐Teng Decoction for Treatment of Rheumatoid Arthritis. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202403454
BibTeX
@article{Zou2025,
author = {Zou, Wei and Wang, Bangyong and Feng, Xiaoqing and Lai, Chunhua and Tan, Qingang},
title = {Ultra‐High‐Performance Liquid Chromatography‐Tandem Mass Spectrometry Combined With Network Pharmacology to Elucidate the Bioactive Ingredients and Potential Mechanism of Wu‐Teng Decoction for Treatment of Rheumatoid Arthritis},
journal = {Chemistry & Biodiversity},
year = {2025},
doi = {10.1002/cbdv.202403454}
}
EUVIMED